# Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pioglitazone-and-risk-of-cardiovascular-events-in-patients-with-type-2-diabetes/

## Facts

| Field | Value |
| --- | --- |
| Author Names | A. Michael Lincoff,Kathy Wolski,Stephen J. Nicholls,Steven E. Nissen |
| Citations | 1,266 |
| DOI | 10.1001/jama.298.10.1180 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1990724339 |
| PMID | 17848652 |
| Type | review |
| Year | 2007 |

## Paper authors

- [A. Michael Lincoff](https://scholariq.org/researchers/a-michael-lincoff/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Peroxisome Proliferator-Activated Receptors](https://scholariq.org/topics/peroxisome-proliferator-activated-receptors/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.